FDAFDA · Food and drugs·Recall number D-003-2013
Nimodipine Capsules 30 mg, Rx Only, For Institutional Use Only, a) 30-count unit dose Capsules (5x6 blister cards per carton), NDC 57664-135-64, b) 100-count unit dose Capsules (25x4 blister cards per carton), NDC 57664-135-65, Distributed by: Caraco Pharmaceutical Laboratories, Ltd. Detroit, MI 48202 Affiliate of Sun Pharmaceutical Industries, Inc.
Published October 10, 2012 · Recall initiated: August 21, 2012
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: Presence of crystals of Nimodipine within the capsule solution.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Manufacturer
- Caraco Pharmaceutical Laboratories Ltd.
- Distributor
- One direct account - Caraco Pharmaceutical Labroatories, LTD Detroit, Michigan 78 sub accounts
- Lot
- Lot: a) 3305.039B, Exp 07/13; b) 3305.039A, Exp 07/13
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.